Medpace Holdings, Inc. Files 8-K on Financials
Ticker: MEDP · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1668397
| Field | Detail |
|---|---|
| Company | Medpace Holdings, Inc. (MEDP) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: MEDP
TL;DR
MEDPACE filed an 8-K on 10/22/25 for financial updates.
AI Summary
Medpace Holdings, Inc. filed an 8-K on October 22, 2025, reporting on its financial condition and results of operations. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This 8-K filing signals that Medpace Holdings, Inc. is providing updated information regarding its financial performance and operational status to the SEC and the public.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for financial condition and results of operations, with no immediate indication of adverse events.
Key Players & Entities
- Medpace Holdings, Inc. (company) — Registrant
- October 22, 2025 (date) — Date of earliest event reported
- 5375 Medpace Way Cincinnati, Ohio 45227 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Medpace Holdings, Inc.?
The primary purpose of this 8-K filing is to report on Medpace Holdings, Inc.'s Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.
On what date was this 8-K report filed or made effective?
This 8-K report was filed as of October 22, 2025.
What is Medpace Holdings, Inc.'s principal executive office address?
Medpace Holdings, Inc.'s principal executive office is located at 5375 Medpace Way, Cincinnati, Ohio 45227.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Medpace Holdings, Inc.'s state of incorporation and IRS Employer Identification Number?
Medpace Holdings, Inc. is incorporated in Delaware and its IRS Employer Identification Number is 32-0434904.
Filing Stats: 549 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-10-22 16:15:28
Key Financial Figures
- $0.01 — hange on which registered Common Stock $0.01 par value MEDP NASDAQ Global Select Mar
Filing Documents
- medp-20251022.htm (8-K) — 26KB
- medp-20251022exx991.htm (EX-99.1) — 172KB
- medpace-logoxonxwhitea.jpg (GRAPHIC) — 10KB
- 0001668397-25-000108.txt ( ) — 340KB
- medp-20251022.xsd (EX-101.SCH) — 2KB
- medp-20251022_lab.xml (EX-101.LAB) — 21KB
- medp-20251022_pre.xml (EX-101.PRE) — 12KB
- medp-20251022_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On October 22, 2025, the Company issued a press release announcing its financial results for the three and nine months ended September 30, 2025. The full text of the press release was posted on the Company's internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated October 2 2 , 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MEDPACE HOLDINGS, INC. Date: October 22, 2025 By: /s/ Kevin M. Brady Kevin M. Brady, Chief Financial Officer